인쇄하기
취소

MSD’s HIV / AIDS treatment ISENTRESS was designated as first line drug with no treatment-experienced HIV / AIDS patients

Published: 2014-02-13 06:56:00
Updated: 2014-02-13 17:53:25

MSD’s HIV / AIDS treatment ISENTRESS was designated as first line drug with no treatment-experienced HIV / AIDS patients

(Yakup Shinmoon)

On Feb 10, MSD Korea announced that the HIV / AIDS treatment ISENTRESS (ingredient: raltegravil) was designated as first line drug with no treatment-experienced HIV / AIDS patients in the revised clinical practice guideline recommendation for the diagnosis ...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.